CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
CURRENT ASSETS
Cash and cash equivalents	$ 31,465	$ 29,487
Trade accounts and grants receivable, net	979	1,042
Inventory	297	266
Landlord receivable	2,771	378
Prepaid expenses and other current assets	1,492	1,232
Total current assets	37,004	32,405
Equipment, net and construction in progress (see Note 4)	5,652	2,858
Deferred license fees	282	337
Deposits	446	443
Other long-term assets	6	10
Intangible assets, net	36,220	38,848
TOTAL ASSETS	79,610	74,901
CURRENT LIABILITIES
Accounts payable and accrued liabilities	6,604	6,803
Capital lease liability, current portion	58	58
Related party convertible debt, net of discount (see Note 8)	238	60
Deferred grant income	1,932	0
Deferred license and subscription revenue, current portion	360	208
Total current liabilities	9,192	7,129
LONG-TERM LIABILITIES
Deferred tax liabilities, net	2,067	4,515
Deferred rent liabilities, net of current portion	36	97
Lease liability	3,331	378
Capital lease, net of current portion	3	31
Other long-term liabilities	30	28
Total long-term liabilities	$ 5,467	$ 5,049
Commitments and contingencies (Note 8)
SHAREHOLDERS' EQUITY
Series A Convertible Preferred Stock, no par value, authorized 2,000 shares as of June 30, 2015 and December 31, 2014; 70 issued and outstanding as of June 30, 2015 and December 31, 2014	$ 3,500	$ 3,500
Common stock, no par value, authorized 125,000 shares as of June 30, 2015 and December 31, 2014; 83,281 issued and 78,387 outstanding as of June 30, 2015 and 83,122 issued and 78,228 outstanding at December 31, 2014	235,555	234,850
Accumulated other comprehensive income/(loss)	(131)	186
Accumulated deficit	(202,055)	(182,190)
Treasury stock at cost: 4,894 shares at June 30, 2015 and at December 31, 2014	(19,890)	(19,890)
BioTime, Inc. shareholders' equity	16,979	36,456
Non-controlling interest	47,972	26,267
Total shareholders' equity	64,951	62,723
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 79,610	$ 74,901